4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-066881
Chief Development Officer sold 30,000 shares at $32.00 ($960,000)
- Chief Development Officer acquired 30,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Guyer William · Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +30,000 | $19.26 | $577,800 | 36,039 | D |
| 2024-05-28 | Sale : show line 2 in the form 10b5-1 | −30,000 | $32.00 | $960,000 | 6,039 | D |
| Open-market sales · 30,000 sh · avg $32.00 · $960,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-28 | Exercise or conversion : show line 3 in the form 10b5-1 Stock option (right to buy) | −30,000 | 60,000 | D |
Loading xslF345X05/ownership.xml…